Salidroside and exercise performance in healthy active young adults - an exploratory, randomized, double-blind, placebo-controlled study

被引:0
|
作者
Schwarz, Neil A. [1 ,2 ]
Stratton, Matthew T. [1 ]
Colquhoun, Ryan J. [1 ,2 ]
Manganti, Alexia M. [1 ]
Sherbourne, Margaux [3 ]
Mourey, Florian [3 ]
White, Caitlyn C. [1 ]
Day, Heather [1 ]
Dusseault, Micaela C. [1 ]
Hudson, Geoffrey M. [1 ]
Vickery, Christopher R. [4 ]
Schachner, Holly C. [5 ]
Kasprzyk, Philip G. [5 ]
Weng, Jing-Ke [5 ,6 ,7 ,8 ]
机构
[1] Univ S Alabama, Dept Hlth Kinesiol & Sport, Exercise & Nutr Res Grp ENRG, Mobile, AL 36688 USA
[2] Univ S Alabama, Frederick C Whiddon Coll Med, Dept Physiol & Cell Biol, Mobile, AL USA
[3] Gnosis Lesaffre Lesaffre Grp, Dept Res & Applicat, Marcq En Baroeul, France
[4] Recombia Biosci Lesaffre, Bedford, MA USA
[5] DoubleRainbow Biosci Inc, Cambridge, MA USA
[6] Northeastern Univ, Inst Plant Human Interface, Boston, MA 02120 USA
[7] Northeastern Univ, Dept Chem & Chem Biol, Dept Bioengn, Boston, MA USA
[8] Northeastern Univ, Dept Chem Engn, Boston, MA USA
关键词
Salidroside; rhodiola rosea; adaptogen; high-intensity interval exercise; oxygen consumption; golden root; RHODIOLA-ROSEA L; OXIDATIVE STRESS; EXTRACT SHR-5; KINASE; PROTEIN; AMPK;
D O I
10.1080/15502783.2024.2433744
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundRhodiola rosea extract is purported to improve physical performance and support resilience to stress. Salidroside is considered to be one of the main constituents responsible for the ergogenic actions of R. rosea. However, R. rosea extract contains relatively little salidroside and cultivation of R. rosea is challenging as it is mainly found in high-altitude, cold regions. Additionally, the R. rosea plant is subject to conservation concerns because of its growing popularity. The purpose of this exploratory study was to evaluate the short-term effects of pure, biosynthetic salidroside supplementation on exercise performance, mood state, and markers of inflammation and muscle damage in healthy active young adults. MethodsFifty participants (30 M, 20F; 21 +/- 4 yrs; 173 +/- 8 cm; 74 +/- 13 kg) were randomly assigned to either salidroside (60 mg/day for 16 days) or placebo supplementation and underwent peak oxygen uptake (VO2 peak), intermittent time-to-exhaustion (TTE), and local muscular endurance assessments, along with mood state evaluations using the Profile of Mood States (POMS). Blood samples were analyzed for erythropoietin, myoglobin, creatine kinase-MM, and C-reactive protein. ResultsSalidroside supplementation enhanced overall percent predicted oxygen uptake during high-intensity intermittent exercise (p < 0.01). An increase in serum myoglobin was observed 24 hours following exercise in the placebo group (p = 0.02) compared with baseline whereas no statistically significant increase was observed for the salidroside group indicating reduced exercise-induced muscle damage. Placebo group experienced a decrease in number of intervals performed during the TTE test (p = 0.03), and a decrease in friendliness (p < 0.01) and an increase in fatigue-inertia (p < 0.01) as reported by POMS. The salidroside group exhibited stable mood states and maintained performance levels during the time-to-exhaustion test. ConclusionSalidroside supplementation may enhance oxygen utilization and mitigate exercise-induced muscle damage and fatigue, warranting further research on its long-term effects and potential as an adaptogen for active individuals.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] The effects of palatinose on attention and cerebral blood flow in healthy adults: A randomized double-blind placebo-controlled crossover study
    Yamamoto, Natsumi
    Sakazaki, Miki
    Nagai, Yukie
    Shoji, Masanori
    Kawashima, Ryuta
    BRAIN RESEARCH, 2023, 1820
  • [32] A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults
    Schoenberg, Mike R.
    Rum, Ruba S.
    Osborn, Katie E.
    Werz, Mary Ann
    EPILEPSIA, 2017, 58 (09) : 1566 - 1574
  • [33] The effect of mirtazapine on cerebrovascular reactivity - A randomized, double-blind placebo-controlled study in healthy volunteers
    Schwertfeger, N
    Neu, P
    Heuser, I
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 264 - 264
  • [34] Ergogenic Effects of Sodium Bicarbonate on Resistance Exercise: A Randomized, Double-Blind, Placebo-Controlled Study
    Varovic, Dorian
    Grgic, Jozo
    Schoenfeld, Brad Jon
    Vuk, Sasa
    JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 2023, 37 (08) : 1600 - 1608
  • [35] A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia
    Rees, David C.
    Kilinc, Yurdanur
    Unal, Selma
    Dampier, Carlton
    Pace, Betty S.
    Kaya, Banu
    Trompeter, Sara
    Odame, Isaac
    Mahlangu, Johnny
    Unal, Sule
    Brent, Julie
    Grosse, Regine
    Fuh, Beng R.
    Inusa, Baba P. D.
    Koren, Ariel
    Leblebisatan, Goksel
    Levin, Carina
    McNamara, Elizabeth
    Meiser, Karin
    Hom, Douglas
    Oliver, Stephen J.
    BLOOD, 2022, 139 (17) : 2642 - 2652
  • [36] The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: An exploratory, randomized, double-blind, placebo-controlled trial
    Zenk, JL
    Helmer, TR
    Kuskowski, MA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (07): : 430 - 442
  • [37] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [38] A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain
    Rauck, Richard L.
    Wallace, Mark S.
    Leong, Michael S.
    MineHart, Michael
    Webster, Lynn R.
    Charapata, Steven G.
    Abraham, Jacob E.
    Buffington, Daniel E.
    Ellis, David
    Kartzinel, Ronald
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 31 (05) : 393 - 406
  • [39] A double-blind, randomized, placebo-controlled exploratory study of SYN118 in restless legs syndrome
    Benes, H.
    Eisensehr, I.
    Hoegl, B.
    Meya, U.
    Sarnecki, M.
    Kohnen, R.
    Oertel, W.
    MOVEMENT DISORDERS, 2011, 26 : S363 - S363
  • [40] A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD
    Kratochvil, Christopher J.
    Vaughan, Brigette S.
    Stoner, Julie A.
    Daughton, Joan M.
    Lubberstedt, Brian D.
    Murray, Desiree W.
    Chrisman, Allan K.
    Faircloth, Melissa A.
    Itchon-Ramos, Nilda B.
    Kollins, Scott H.
    Maayan, Lawrence A.
    Greenhill, Laurence L.
    Kotler, Lisa A.
    Fried, Jane
    March, John S.
    PEDIATRICS, 2011, 127 (04) : E862 - E868